FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Salmeterol Xinafoate Inhalational Powder
Status: Discontinuation
»Therapeutic Categories: Pulmonary/Allergy

GlaxoSmithKline (New 04/23/2021)

Company Contact Information:

Presentation Posting Date Related Information
50 mcg, 28 blisters (NDC 0173-0520-00) 04/23/2021 This product discontinuation is a business-related decision. GSK has ceased distribution of this product. The 60-blister presentation will continue to be available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English